Gerostate Alpha
Gordon is Chief Academic Officer at the Buck Institute for Research on Aging and specializes in the properties of small molecules to extend lifespan, having been internationally recognized for his work on aging with numerous awards and prizes.
Gordon obtained his B.Sc and PhD at the University of Glasgow before working in pharmaceuticals. After several years, he rejoined academia to collaborate with Simon Melov, joining the Buck Institute in 2000, where the two have worked together ever since.
This person is not in the org chart
This person is not in any offices
Gerostate Alpha
Gerostate Alpha is a new pharmaceutical company dedicated to treating aging and age-related disease.